← Evidence map

Observational studyPediatric nephrology (Berlin, Germany)2026

Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy.

Stuart L Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41652244